ALKALINE PHOSPHATASE (ALP) NORMALIZATION AT 12 WEEKS AND HEMATOLOGIC PROFILE WITH REPEATED DOSING IN PATIENTS WITH BONE METASTASES FROM CASTRATION-RESISTANT PROSTATE CANCER (CRPC) TREATED WITH RADIUM-223 (ALPHARADIN™)

ALKALINE PHOSPHATASE (ALP) NORMALIZATION AT 12 WEEKS AND HEMATOLOGIC PROFILE WITH REPEATED DOSING IN PATIENTS WITH BONE METASTASES FROM CASTRATION-RESISTANT PROSTATE CANCER (CRPC) TREATED WITH RADIUM-223 (ALPHARADIN™)

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Parker, C, O'Bryan-Tear, CG, Bolstad, B, Lokna, A, Garcia-Vargas, J, Nilsson, S
Format: Tagungsbericht
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page 335
container_title
container_volume 10
creator Parker, C
O'Bryan-Tear, CG
Bolstad, B
Lokna, A
Garcia-Vargas, J
Nilsson, S
description
doi_str_mv 10.1016/S1569-9056(11)61068-3
format Conference Proceeding
fullrecord <record><control><sourceid>swepub</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_613182</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_swepub_ki_se_613182</sourcerecordid><originalsourceid>FETCH-swepub_primary_oai_swepub_ki_se_6131823</originalsourceid><addsrcrecordid>eNqVjk1OwzAQhb0AifJzBKRZJotAnFArXZpk2lhNbMs2qsQmClKQyo-oGiHEnpP0Wuw4CU5TsWc1b957mm8IuaTxFY0pu7Z0ymbRLJ6ygNKQ0ZhlUXpEJn_2CTnt-6c4plnGbibkm1dLXgmJoEtldckdtwgBr3QIUpnaZ_fcCSWBO6AJrBCXFrgsoMSaO1WphchBGzUXFcJKuBIMauQOCyiUFXIBQoL2J1A6OxZulcfV6EkDzMLcqBpyv5k9KTJohY-kG-564dCnMkcDQW50HoIzI2DE8ULc1VGSpPu3Sz4Y8udrF56T48f2pe8uDvOMRHN0eRn1H93m_aHZbNev7fazeWvXzcF69qprGE1plqT_7f8CWVVsYw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>conference_proceeding</recordtype></control><display><type>conference_proceeding</type><title>ALKALINE PHOSPHATASE (ALP) NORMALIZATION AT 12 WEEKS AND HEMATOLOGIC PROFILE WITH REPEATED DOSING IN PATIENTS WITH BONE METASTASES FROM CASTRATION-RESISTANT PROSTATE CANCER (CRPC) TREATED WITH RADIUM-223 (ALPHARADIN™)</title><source>Elsevier ScienceDirect Journals</source><creator>Parker, C ; O'Bryan-Tear, CG ; Bolstad, B ; Lokna, A ; Garcia-Vargas, J ; Nilsson, S</creator><creatorcontrib>Parker, C ; O'Bryan-Tear, CG ; Bolstad, B ; Lokna, A ; Garcia-Vargas, J ; Nilsson, S</creatorcontrib><identifier>ISSN: 1569-9056</identifier><identifier>DOI: 10.1016/S1569-9056(11)61068-3</identifier><language>eng</language><ispartof>European urology supplements : official journal of the European Association of Urology, 2011, Vol.10 (2), p.335</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,309,310,776,780,785,786,881,4036,4037,23909,23910,25118,27902</link.rule.ids><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:122320900$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Parker, C</creatorcontrib><creatorcontrib>O'Bryan-Tear, CG</creatorcontrib><creatorcontrib>Bolstad, B</creatorcontrib><creatorcontrib>Lokna, A</creatorcontrib><creatorcontrib>Garcia-Vargas, J</creatorcontrib><creatorcontrib>Nilsson, S</creatorcontrib><title>ALKALINE PHOSPHATASE (ALP) NORMALIZATION AT 12 WEEKS AND HEMATOLOGIC PROFILE WITH REPEATED DOSING IN PATIENTS WITH BONE METASTASES FROM CASTRATION-RESISTANT PROSTATE CANCER (CRPC) TREATED WITH RADIUM-223 (ALPHARADIN™)</title><title>European urology supplements : official journal of the European Association of Urology</title><issn>1569-9056</issn><fulltext>true</fulltext><rsrctype>conference_proceeding</rsrctype><creationdate>2011</creationdate><recordtype>conference_proceeding</recordtype><recordid>eNqVjk1OwzAQhb0AifJzBKRZJotAnFArXZpk2lhNbMs2qsQmClKQyo-oGiHEnpP0Wuw4CU5TsWc1b957mm8IuaTxFY0pu7Z0ymbRLJ6ygNKQ0ZhlUXpEJn_2CTnt-6c4plnGbibkm1dLXgmJoEtldckdtwgBr3QIUpnaZ_fcCSWBO6AJrBCXFrgsoMSaO1WphchBGzUXFcJKuBIMauQOCyiUFXIBQoL2J1A6OxZulcfV6EkDzMLcqBpyv5k9KTJohY-kG-564dCnMkcDQW50HoIzI2DE8ULc1VGSpPu3Sz4Y8udrF56T48f2pe8uDvOMRHN0eRn1H93m_aHZbNev7fazeWvXzcF69qprGE1plqT_7f8CWVVsYw</recordid><startdate>2011</startdate><enddate>2011</enddate><creator>Parker, C</creator><creator>O'Bryan-Tear, CG</creator><creator>Bolstad, B</creator><creator>Lokna, A</creator><creator>Garcia-Vargas, J</creator><creator>Nilsson, S</creator><scope>ADTPV</scope><scope>BNKNJ</scope></search><sort><creationdate>2011</creationdate><title>ALKALINE PHOSPHATASE (ALP) NORMALIZATION AT 12 WEEKS AND HEMATOLOGIC PROFILE WITH REPEATED DOSING IN PATIENTS WITH BONE METASTASES FROM CASTRATION-RESISTANT PROSTATE CANCER (CRPC) TREATED WITH RADIUM-223 (ALPHARADIN™)</title><author>Parker, C ; O'Bryan-Tear, CG ; Bolstad, B ; Lokna, A ; Garcia-Vargas, J ; Nilsson, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-swepub_primary_oai_swepub_ki_se_6131823</frbrgroupid><rsrctype>conference_proceedings</rsrctype><prefilter>conference_proceedings</prefilter><language>eng</language><creationdate>2011</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Parker, C</creatorcontrib><creatorcontrib>O'Bryan-Tear, CG</creatorcontrib><creatorcontrib>Bolstad, B</creatorcontrib><creatorcontrib>Lokna, A</creatorcontrib><creatorcontrib>Garcia-Vargas, J</creatorcontrib><creatorcontrib>Nilsson, S</creatorcontrib><collection>SwePub</collection><collection>SwePub Conference</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Parker, C</au><au>O'Bryan-Tear, CG</au><au>Bolstad, B</au><au>Lokna, A</au><au>Garcia-Vargas, J</au><au>Nilsson, S</au><format>book</format><genre>proceeding</genre><ristype>CONF</ristype><atitle>ALKALINE PHOSPHATASE (ALP) NORMALIZATION AT 12 WEEKS AND HEMATOLOGIC PROFILE WITH REPEATED DOSING IN PATIENTS WITH BONE METASTASES FROM CASTRATION-RESISTANT PROSTATE CANCER (CRPC) TREATED WITH RADIUM-223 (ALPHARADIN™)</atitle><btitle>European urology supplements : official journal of the European Association of Urology</btitle><date>2011</date><risdate>2011</risdate><volume>10</volume><issue>2</issue><spage>335</spage><pages>335-</pages><issn>1569-9056</issn><doi>10.1016/S1569-9056(11)61068-3</doi></addata></record>
fulltext fulltext
identifier ISSN: 1569-9056
ispartof European urology supplements : official journal of the European Association of Urology, 2011, Vol.10 (2), p.335
issn 1569-9056
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_613182
source Elsevier ScienceDirect Journals
title ALKALINE PHOSPHATASE (ALP) NORMALIZATION AT 12 WEEKS AND HEMATOLOGIC PROFILE WITH REPEATED DOSING IN PATIENTS WITH BONE METASTASES FROM CASTRATION-RESISTANT PROSTATE CANCER (CRPC) TREATED WITH RADIUM-223 (ALPHARADIN™)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T01%3A08%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-swepub&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=proceeding&rft.atitle=ALKALINE%20PHOSPHATASE%20(ALP)%20NORMALIZATION%20AT%2012%20WEEKS%20AND%20HEMATOLOGIC%20PROFILE%20WITH%20REPEATED%20DOSING%20IN%20PATIENTS%20WITH%20BONE%20METASTASES%20FROM%20CASTRATION-RESISTANT%20PROSTATE%20CANCER%20(CRPC)%20TREATED%20WITH%20RADIUM-223%20(ALPHARADIN%E2%84%A2)&rft.btitle=European%20urology%20supplements%20:%20official%20journal%20of%20the%20European%20Association%20of%20Urology&rft.au=Parker,%20C&rft.date=2011&rft.volume=10&rft.issue=2&rft.spage=335&rft.pages=335-&rft.issn=1569-9056&rft_id=info:doi/10.1016/S1569-9056(11)61068-3&rft_dat=%3Cswepub%3Eoai_swepub_ki_se_613182%3C/swepub%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true